Search

everythinglearnresearchcommunity

for

Search:↓

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Topical minoxidil 5% is better for treating female pattern hair loss than topical sildenafil 1%.

Different hair loss patterns may be linked to varying male hormone levels.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Laser device increases hair density, safe for treating hair loss in men and women.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Smoking may contribute to hair loss in men.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Some women with common hair loss may develop permanent hair loss.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Finasteride can slow hair loss and promote growth in postmenopausal women.

To manage hair loss in adult women, find the cause and treat it accordingly.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Finasteride improves hair density and thickness in women with hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Genetics and hormones cause hair loss; finasteride treats it safely.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.